S. 5339, also known as the “Medical Innovation Act of 2024,” aims to increase investments in medical research by collecting supplemental payments from pharmaceutical manufacturers. The bill targets companies that have entered into specific settlement agreements and reported...
Simple Explanation
The bill wants some big drug companies to give extra money if they make a lot of money, so scientists can do more research to find new medicines and help keep people healthy.